LncRNA FTH1P3:癌症相关治疗发展的新生物标志物
1Department of Medical Biotechnology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Current molecular medicine
|July 26, 2023
概括
像FTH1P3这样的长非编码RNA (lncRNAs) 越来越多地被认为是它们在癌症中的作用. 这篇评论强调了FTH1P3的重点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNAs (lncRNAs) 是调节分子,在包括癌症在内的各种疾病中发挥作用.
- 费里丁重链1伪基3 (FTH1P3) 是一种在口腔状细胞癌和其他恶性瘤中发现的新型lncRNA.
- 过度表达FTH1P3与癌症患者的不良临床结果有关.
研究的目的:
- 审查和综合有关lncRNA FTH1P3.3的当前研究.
- 阐明FTH1P3在癌症中的生物功能和调节机制.
- 讨论FTH1P3在癌症诊断和预后方面的潜在临床相关性.
主要方法:
- 对已发表的关于FTH1P3.3.的研究进行系统的文献审查.
- 对FTH1P3在癌细胞增殖,入侵,转移,化学抵抗和亡中的作用的实验数据的分析.
- 检查了与患者存活率和预后相关联的FTH1P3表达的临床数据.
主要成果:
- FTH1P3与促进癌症进展有关,包括增强细胞增殖,入侵和转移.
- 在各种癌症类型中,FTH1P3有助于化学抵抗,并抑制各种癌症类型的亡.
- 过度表达FTH1P3显着与预后不佳和整体存活率降低有关.
结论:
- FTH1P3是一个关键的瘤性 lncRNA,在多种人类癌症中起着重要作用.
- 了解FTH1P3的机制可能会导致新的治疗策略和癌症的生物标志物.
- 需要对FTH1P3进行进一步的研究,以探索其充分的临床潜力.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K